Location: Boston, MA
CIK: 0001082621 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 12, 2021
Total Value: $1.706B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 1,883,445 | $267M | 15.6% | — | — | COM | 037833100 |
| RPRX | ROYALTY PHARMA PLC | 7,142,856 | $258M | 15.1% | — | — | SHS CLASS A | G7709Q104 |
| META | FACEBOOK INC | 713,073 | $242M | 14.2% | — | — | CL A | 30303M102 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $223M | 13.0% | — | — | COM | 80874P109 |
| GOOGL | ALPHABET INC | 61,070 | $163M | 9.6% | — | — | CAP STK CL A | 02079K305 |
| AFRM | AFFIRM HLDGS INC | 753,804 | $89.8M | 5.3% | — | — | COM CL A | 00827B106 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $82.27M | 4.8% | — | — | COM | 00288U106 |
| QQQ | INVESCO QQQ TR | 101,448 | $36.31M | 2.1% | — | — | UNIT SER 1 | 46090E103 |
| RXRX | RECURSION PHARMACEUTICALS IN | 1,509,254 | $34.73M | 2.0% | — | — | CL A | 75629V104 |
| IVV | ISHARES TR | 65,342 | $28.15M | 1.6% | — | — | CORE S&P500 ETF | 464287200 |
| TXG | 10X GENOMICS INC | 186,143 | $27.1M | 1.6% | — | — | CL A COM | 88025U109 |
| SANA | SANA BIOTECHNOLOGY INC | 1,163,601 | $26.2M | 1.5% | — | — | COM | 799566104 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $18.44M | 1.1% | — | — | COM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $17.06M | 1.0% | — | — | COM | 75943R102 |
| — | ROCKET LAB USA INC | 1,000,000 | $16.13M | 0.9% | — | — | COM | 773122106 |
| GLD | SPDR GOLD TR | 91,955 | $15.1M | 0.9% | — | — | GOLD SHS | 78463V107 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $14.39M | 0.8% | — | — | COM | 74006W108 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,069,600 | $14.2M | 0.8% | — | — | COM | 74623V103 |
| TNYA | TENAYA THERAPEUTICS INC | 673,270 | $13.9M | 0.8% | — | — | COM | 87990A106 |
| — | GENERATION BIO CO | 510,354 | $12.79M | 0.7% | — | — | COM | 37148K100 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $11.59M | 0.7% | — | — | COM | 359616109 |
| — | KINNATE BIOPHARMA INC | 498,001 | $11.46M | 0.7% | — | — | COM | 49705R105 |
| — | MELI KASZEK PIONEER CORP | 1,000,000 | $11.05M | 0.6% | — | — | CLASS A ORD | G5S74L106 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $9.493M | 0.6% | — | — | COM | 729139105 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $9.43M | 0.6% | — | — | COM | 67080M103 |
| TNGX | TANGO THERAPEUTICS INC | 708,385 | $9.159M | 0.5% | — | — | COM | 87583X109 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 162,699 | $8.215M | 0.5% | — | — | FTSE DEV MKT ETF | 921943858 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 229,144 | $5.855M | 0.3% | — | — | COM | 69404D108 |
| — | SURROZEN INC | 826,852 | $5.854M | 0.3% | — | — | COM | 86889P109 |
| IJR | ISHARES TR | 49,559 | $5.411M | 0.3% | — | — | CORE S&P SCP ETF | 464287804 |
| — | FS DEVELOPMENT CORP II | 400,000 | $3.98M | 0.2% | — | — | COM CL A | 30318F100 |
| VWO | VANGUARD INTL EQUITY INDEX F | 73,804 | $3.691M | 0.2% | — | — | FTSE EMR MKT ETF | 922042858 |
| IJH | ISHARES TR | 12,683 | $3.337M | 0.2% | — | — | CORE S&P MCP ETF | 464287507 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $2.535M | 0.1% | — | — | COM | 24343R106 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $2.421M | 0.1% | — | — | COM | 55910K108 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $1.742M | 0.1% | — | — | COM | 26818M108 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $1.01M | 0.1% | — | — | COM | 36870G105 |
| — | SERES THERAPEUTICS INC | 131,847 | $918K | 0.1% | — | — | COM | 81750R102 |
| SRZNW | SURROZEN INC | 108,333 | $124K | 0.0% | — | — | *W EXP 08/01/203 | 86889P117 |
| AMPL | AMPLITUDE CL A ORD (NMQ) | 540 | $29,000 | 0.0% | — | — | CLASS A ORD | 03213A104 |